Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
Julia Etchin(Dana-Farber Cancer Institute), A. Thomas Look(Dana-Farber Cancer Institute), Qingxiang Sun(University of Electronic Science and Technology of China), Amanda L. Christie(Dana-Farber Cancer Institute), Takaomi Sanda(National University of Singapore), Carles Barceló(Universitat de Vic - Universitat Central de Catalunya), Sharon Shacham(Roche (Switzerland)), Yuh Min Chook(The University of Texas Southwestern Medical Center), Alex Kentsis(Memorial Sloan Kettering Cancer Center), Scott J. Rodig(Brigham and Women's Hospital), Andrew L. Kung(Memorial Sloan Kettering Cancer Center), Marc R. Mansour(Great Ormond Street Hospital), Michael Kauffman(Roche (Switzerland)), Alicia Farmer(The University of Texas Southwestern Medical Center), Zhong-Zhe Zhang(The University of Texas Southwestern Medical Center), Dilara McCauley(Karyopharm Therapeutics (United States))
Cited by 193
Related Papers
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
|Cancer Cell|2002|1.1k
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937